% | $
Quotes you view appear here for quick access.

aTyr Pharma Inc. Message Board

  • budwashougal budwashougal Feb 11, 2010 11:55 AM Flag

    New debt

    <<$250 million of three-year notes launched at 200 basis points more than comparable U.S. Treasuries.

    Also expected are $500 million five-year notes launched at 210 basis points over Treasuries and $750 million of 10-year notes launched at 232 basis points more than Treasuries >>

    Keeping ahead of the Treasuries. I wonder what T-bill rates will be in the next 5-10 years?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Makes you wonder what they need the cash infusion for. As far as I can see, they don't owe cash from last rounds of mergers. If they are borrowing cash, my guess is they are making a play to buy someone else, and not being bought by GE.
      Course who knows what Lucier is up to.

      • 1 Reply to weasel_in_my_trousers
      • it is not clear whether that 10.4 billion buyout includes the newly priced debt or not.

        I would doubt it because without the 1.5b then that 10.4 billion would be a ~18% premium of the current life's enterprise value, or commonly quoted as buy-out value.

        EV= market value of equity + market value of debt - cash holdings

        the EV is the least amount of $ you would expect to pay to buy a firm.

        using all the public financial data you can see that 10.4 billion is about 18% premium of current value w/o the new debt. it's not clear why Life went on to borrow that much debt if were not for new investment.

        the new stock price for life would then be at least 58/share with or without debt.

        I have found that for a few weeks there are people buying big lots of life shares after market hours, also some time ago some one posted a link that the Feb call volume of life is significently higher than puts.
        I suspect there is a news leak and if you factor in the recent plant close and debt issue, something big is gonna happen very soon.
        either life gets bought by GE, or life goes out and make a major buyout.
        if the GE rumor is ture then what's the odds both events happen and how it would inflate the stock price.
        we will see. now it's those shorts that can not sleep well.

    • there are actually people still on this board.

      Issuing more debt is considered a lot better than issuing new stock shares from the market's view.
      the rationale is quite simple: if you issue more shares to finance new investments it signals the mkt that the company thinks its stock is overvalued. whereas issuing debt has few positive impact:
      1st. more debt would add more tax benefits to the total future cash flow. (tax benefits are not cash flow but is certainly calculated as future cash flow in the valuation of a company).
      the increase of FCF would significantly increase its valuation, thus its stock price.

      2. Debt increase would add more pressure to the current managment for a better Operating performance. it shows that the managment team is confident about their ability to repay all the debt.

      by the way, have anyone heard about the M&A rumor about GE would acquire life for a premium of 17% soon? words from wall street being that GE healthcare unit would offer a tender offer for life tech for 17% premium based on its Jan 29th closed price.

      if any one heard this could you please comfirm or tell more about this?


3.180.00(0.00%)Sep 30 4:00 PMEDT